ckgt 获取中国仙人掌型香烟的专利 www.RedChip.com

新闻快递

时间


事项


2008-9-18
标题：中国康大仙人掌生物技术有限公司获取中国仙人掌型香烟的专利

导语：此种类型的香烟提供与尼古丁型香烟相同的味觉和享受，但具有更有利健康的特性

内容摘要：公司从中国国家知识产权局获取了仙人掌型香烟的发明专利，专利号为2006100102091。此种产品将会使吸烟者更加的健康。与传统的香烟相比，其可以降低70%的焦油和尼古丁含量。除了减少吸引的危害外，其中所包含的金银花和银杏叶可以产生医疗保健的功效。康大仙人掌的总裁评论到：“我们已经开始了试生产，并且相信此种产品可以获取一定比例的市场份额”。

2008-8-15
标题：中国康大仙人掌公布创纪录的第二季度经营业绩

导语：收入劲升35%引导创纪录的盈利

内容摘要：公司报告的收入为500万美元，与2007年度的第二季度370万美元的数据相比增长34.9%。收入增长是由于公司的“仙人掌蛋白营养素”、“仙人掌钙肽软胶囊”和“仙人掌舒欣胶囊”等产品被中国消费者接受度的提高及公司扩大的分销网络。截止2008年6月30日三个月的毛利润为150万美元，与去年同期的140万美元的数据相比增长12.3%。此种增长主要是由于销售额的增长而贡献的。截止2008年6月30日三个月的期间内，税前净利润与去年同期的110万美元相比增长10.2%至今年的120万美元。可分配给普通股股东的净利润增长至100万美元，或$0.06 每股，上年同期的数据分别为90万美元，或$0.05每股。
截止2008年6月30日六个月的期间内，销售收入为780万美元，与上年同期销售收入610万美元的数据相比增长27.7%。税前净利润与去年同期170万美元的数据相比增长13.8%至190万美元。净利润为160万美元，上年同期数据为140万美元。康大的总裁评论到：“我们第二季度的经营业绩反映了我们现存仙人掌产品被更加广泛的接受，同时我们将会加大我们的营销来支持我们新近开发的、令人兴奋的产品，像仙人掌牛饲料和仙人掌鱼饲料，我们期待此种为牛和鱼类开发的具备健康和多产优势的仙人掌产品将会引导我们的销售增长”。

2008-7-21
标题：中国康大仙人掌生物技术开始广告宣传来支持其新产品的销售

内容摘要：公司开始进行广告宣传，同时也取得了公司大股东之一的支持，来营销公司最近发布的两项创新产品。仙人掌牛饲料和仙人掌鱼饲料预计在这个年度内将会产生大约1440万人民币（210万美元）的销售收入。中国康大仙人掌预计采用电视和报纸广告来提升这些新产品的知名度，这些新产品将会为牛提供从仙人掌中提取的养料并且可以达到预防败血症、发炎和增强免疫力的疗效。公司自2003年起开发这些产品，并且在2004年5月纳入国家星火计划，并取得了中国科技成果奖的认证。

2008-7-14
标题：中国康大仙人掌生物技术有限公司发布仙人掌牛饲料和仙人掌鱼饲料

导语：新产品预计增加1440万人民币的年销售收入

内容摘要：公司发布两项创新型产品--仙人掌牛饲料和仙人掌鱼饲料。公司预计今年的未来两个季度内这两个产品将会产生大约1440万人民币（210万美元）的销售收入。这些新产品将会为牛提供从仙人掌中提取的养料并且可以达到预防败血症、发炎和增强免疫力的疗效。公司自2003年起开发这些产品，并且在2004年5月纳入国家星火计划，并取得了中国科技成果奖的认证。

China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch



HARBIN, China, Sept. 10 /Xinhua-PR Newswire-FirstCall/ -- China Kangtai
Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated
grower, developer, manufacturer and marketer of a variety of cactus-based
consumer products, announced today that the Company plans to launch a new
product: Cactus Health Cigarettes.
In order to develop a niche market, to welcome the green-themed 2008
Beijing Olympiad, and in an effort to take advantage of the public's
increasing health awareness stimulated by this event, the Company has
successfully researched and developed a smoking product that uses cactus as
its main ingredient: Cactus Health Cigarettes. The Company has applied for
patent protection for the product at the China National Bureau of
Intellectual Property and expects to gain approval before the end of the
year. The Company believes that this product has huge market potential and
that the sales of the product could have an extremely positive impact on
Company's top and bottom lines. The Company has decided to launch the
product in 2008.
Cactus Health Cigarettes
This product uses dried cactus palms as the main ingredient, together
with dried honeysuckle, dried ginkgo leaves, and a small amount of a plant
based essence, and is made through conventional cigarette production
processes and technologies. This product is a new and healthy alternative
to conventional cigarettes.
The harmful effects of cigarette smoking and the difficulty to quit
smoking are well known. Cigarette production and consumption are especially
high in China. Large numbers of people die every year due to traditional
nicotine cigarette-related diseases, and many also suffer from illnesses
related to second-hand smoke. The launch of cactus health cigarettes is a
Gospel to those who suffer miserably from smoking.
According to The Grand Dictionary of Chinese Medicine and the
Compendium of Materia Medica, as well as many certified tests and analyses
carried out by the Department of Agriculture and the Institute for
Nutrition and Food Safety of the Center of Disease Prevention and Control
of China, cacti contain over 18 kinds of amino acid, carbohydrates, chief
meal fibrin, carotene, vitamin C, vitamin E, vitamin K1, vitamin B1,
vitamin B2, vitamin B6, vitamin B12, smoke acid, folacin, calcium,
phosphorus, iron, potassium, sodium, magnesium, manganese, copper, zinc,
iodine, and selenium. Various cactus products have been shown to provide
health benefits and have been used to treat a variety of health issues
including, diabetes, adiposity, constipation, cholesterol, high blood
pressure, low immunity, and various skin disorders.
China Kangtai owns nearly 400 acres of farmland and grows three species
of Mexican cacti and some of the Company's own cloned species. The Company
owns an R & D institute that has successfully produced 31 product patents,
15 of which have already been approved. It currently produces and sells
four cactus- based product categories: nutraceuticals, which are health and
wellness dietary supplements; beverages, including juice, teas, beer, wine,
and spirits; packaged foods, such as noodles, biscuits and pickles; and raw
and intermediate cactus materials. There are about 36 existing products
under these four categories.
Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech
commented, "Cactus-based products are well-received by the market in China
and show huge growth potential. China Kangtai will continue to develop new
products to meet the demand of the consumers, while penetrating the markets
with its existing products."
Wang concluded, "Our Company remains focused on the quality and
functionality of our products that deliver various health benefits to
consumers. These new products will contribute positively to the Company's
2007 performance and beyond, and accelerate its revenue and profit growth.
With 15 product patents and 16 pending approval, China Kangtai is the
dominant player in the cactus-based consumer product sector."
About China Kangtai Cactus Bio-Tech Inc.
China Kangtai Cactus Bio-Tech, Inc. is a market-leading cactus grower
and producer of cactus-related products with over 387 acres of plants and
an active R&D group that holds 15 product patents and is seeking another 16
in a variety of product categories. China Kangtai's high-quality products
are sold throughout China in supermarkets, food stores, hotels and
restaurants through a growing distribution network that has currently
covered 14 provinces and 4 municipalities.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information about China
Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor
for forward-looking statements provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements
that are not historical facts. These statements can be identified by the
use of forward- looking terminology such as "believe," "expect," "may,"
"will," "should," "project," "plan," "seek," "intend," or "anticipate" or
the negative thereof or comparable terminology, and include discussions of
strategy, and statements about industry trends and China Kangtai Cactus
Bio-tech future performance, operations and products.
This forward-looking information should be considered only in
connection with "Risk Factors" in China Kangtai Cactus Bio-tech's annual
report on Form 10KSB filed with the SEC on April 2, 2007, and its other
current and periodic reports filed with the SEC. China Kangtai Cactus
Bio-tech assumes no obligations to update any forward-looking statements or
information set forth in this press release.
For more information, please contact:

At the Company:

Ren Hu
Vice President
China Kangtai Cactus Bio-tech, Inc.
Phone: [phone]
Email: [e-mail]


Investor Relations:

RedChip Companies, Inc.
Jon Cunningham
Phone: +1-800-RedChip x107
Email: [e-mail] / [e-mail]
Website: http://www.RedChip.com

所有跟帖： 

• 热带火龙果仙人掌科首次在我国北方开花结果 -marketreflections- ♂ (674 bytes) () 10/15/2009 postreply 10:57:17